Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Shareholders Equity (Quarterly) : 757.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 757.49M |
| March 31, 2026 | 704.85M |
| December 31, 2025 | 738.98M |
| September 30, 2025 | 945.57M |
| June 30, 2025 | 1.250B |
| March 31, 2025 | 99.16M |
| December 31, 2024 | 285.38M |
| September 30, 2024 | 483.42M |
| June 30, 2024 | 38.82M |
| March 31, 2024 | -464.81M |
| December 31, 2023 | -331.92M |
| September 30, 2023 | -289.36M |
| June 30, 2023 | -155.74M |
| March 31, 2023 | -44.65M |
| December 31, 2022 | 87.95M |
| September 30, 2022 | -29.96M |
| June 30, 2022 | 44.24M |
| March 31, 2022 | 119.88M |
| December 31, 2021 | 410.47M |
| September 30, 2021 | 504.84M |
| June 30, 2021 | 531.05M |
| March 31, 2021 | 201.64M |
| December 31, 2020 | 275.88M |
| September 30, 2020 | 357.06M |
| June 30, 2020 | 405.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 206.70M |
| December 31, 2019 | 261.67M |
| September 30, 2019 | 304.04M |
| June 30, 2019 | 356.57M |
| March 31, 2019 | 144.14M |
| December 31, 2018 | 208.27M |
| September 30, 2018 | 291.41M |
| June 30, 2018 | 370.64M |
| March 31, 2018 | 434.86M |
| December 31, 2017 | 361.06M |
| September 30, 2017 | 421.30M |
| June 30, 2017 | 83.44M |
| March 31, 2017 | 121.68M |
| December 31, 2016 | 154.48M |
| September 30, 2016 | 217.83M |
| June 30, 2016 | 250.56M |
| March 31, 2016 | 282.46M |
| December 31, 2015 | 311.70M |
| September 30, 2015 | 339.00M |
| June 30, 2015 | 365.34M |
| March 31, 2015 | 164.86M |
| December 31, 2014 | 186.24M |
| September 30, 2014 | 199.27M |
| June 30, 2014 | 111.55M |
| March 31, 2014 | 131.74M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| United Therapeutics Corp. | 6.400B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Biogen, Inc. | 18.85B |
| Gilead Sciences, Inc. | 11.83B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.103B |
| Total Liabilities (Quarterly) | 1.345B |
| Debt to Equity Ratio | 0.9865 |
| Current Ratio | 3.724 |
| Net Debt Paydown Yield | 0.48% |